Giovanni A. Ferrara
Algemeen Directeur bij Medeor Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Giovanni A. Ferrara
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd
8
| Subsidiary | Investment Managers | 8 |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA.
4
| Holding Company | Medical/Nursing Services | 4 |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.
1
| Private Company | Investment Managers | 1 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Giovanni A. Ferrara via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
John Hancock Life Insurance Co. (USA)
John Hancock Life Insurance Co. (USA) Life/Health InsuranceFinance John Hancock Life Insurance Co. (USA) provides investment advice. The firm offers insurance and investment products and services to retail and institutional customers. It is the investment advisor responsible for management of the insurance company and other institutional portfolios. The company is headquartered in Boston, MA. | Life/Health Insurance | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder | |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | Medical Specialties | Chairman | |
Medtronic Ablation Frontiers LLC
Medtronic Ablation Frontiers LLC Medical SpecialtiesHealth Technology Medtronic Ablation Frontiers LLC provides technology solutions for cardiac therapy to cure heart arrhythmias focusing on a trial fibrillation. The firm focuses in the treatment of ablation therapy. The company was founded in 2004 and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member | |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member | |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Animal Diagnostics, Inc.
Advanced Animal Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member | |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Stanford University | College/University | Undergraduate Degree | |
AFFYMAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
Sensitech, Inc.
Sensitech, Inc. Electronic Equipment/InstrumentsElectronic Technology Sensitech, Inc. provides cold chain solutions for monitoring temperature-sensitive and perishable products. Its products encompasses in software, dataloggers, logistics security, chemical and electronic indicator, strip chart recorders, ethylene absorption, facility monitoring, and accessories. The company was founded by Ernest M. Santin in 1990 and is headquartered in Beverly, MA. | Electronic Equipment/Instruments | Director/Board Member | |
University of Utah | College/University | Doctorate Degree | |
St. Anselm College | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree | |
VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Private Equity Investor Private Equity Investor | |
Union Square Ventures LLC
Union Square Ventures LLC Investment ManagersFinance Union Square Ventures LLC (USV) is a venture capital firm founded by Brad R. Burnham and Frederick R. Wilson in 2003. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
Spark Capital Partners LLC
Spark Capital Partners LLC Investment ManagersFinance Spark Capital Partners LLC (Spark Capital) is a venture capital firm founded in 2005 by Todd Dagres, Santo Politi, Alex Finkelstein and Paul Conway. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
The San Diego Blood Bank
The San Diego Blood Bank Medical/Nursing ServicesHealth Services The San Diego Blood Bank provides blood and blood related laboratory services. Its services include blood collection, component preparation, plateletpheresis, plasmapheresis, leukapheresis, washed blood, frozen blood, autologous storage, designated donation services and a reference laboratory. The company was founded by Thomas O'Connell and Frederick G. Hollander in 1950 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Novartis Venture Fund
Novartis Venture Fund Investment ManagersFinance Novartis Venture Fund provides early stage venture capital to companies in Europe, North America and Asia. The fund's focus is on the development of novel therapeutics and platforms, therefore it focuses on such sectors as Biotechnology and Biopharma. The fund makes seed and early stage investments ranging up to USD 30 million per company over its life. The fund makes follow-on and co-investments. | Investment Managers | Corporate Officer/Principal | |
Dartmouth Medical School | College/University | Doctorate Degree | |
Cogent Neuroscience, Inc. | Corporate Officer/Principal | ||
Science Club For Girls | Director/Board Member | ||
Fu Foundation School of Engineering & Applied Science | College/University | Undergraduate Degree | |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor Director/Board Member | |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
KODIAK SCIENCES INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | Medical Specialties | Chief Executive Officer | |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member Director/Board Member | |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
CONTINEUM THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 47 |
Zwitserland | 3 |
Canada | 2 |
Sectoraal
Health Technology | 29 |
Finance | 8 |
Consumer Services | 8 |
Health Services | 4 |
Commercial Services | 3 |
Operationeel
Director/Board Member | 108 |
Corporate Officer/Principal | 34 |
Private Equity Investor | 19 |
Undergraduate Degree | 11 |
Chief Tech/Sci/R&D Officer | 10 |
Sterkste connecties
Insiders | |
---|---|
Henry Skinner | 29 |
Wei Li | 24 |
Steve D. Weinstein | 23 |
Frank Kung | 22 |
Christine Brennan | 20 |
Lauren Silverman | 18 |
Michal Silverberg | 17 |
Inès Holzbaur | 11 |
Juliette Audet | 11 |
Julie Iwashita | 9 |
Veronica Keaveney | 5 |
Michael Zdanowski | 5 |
Colby Suire | 4 |
David Morris | 2 |
- Beurs
- Insiders
- Giovanni A. Ferrara
- Bedrijfsconnecties